FIELD: medicine.
SUBSTANCE: invention relates to biochemistry. Method includes determination of level of polypeptide with said sequence in plasma by means of antigen, where Thr90 of polypeptide is phosphorylated. Also diagnostic sets for detection of presence of tumour metastases are described, for screening for presence of tumour among high risk population, for determination of prognosis for patient, for determination of efficiency of surgery, radiotherapy or chemical therapy with respect to patient with tumour, and/or determination of the time when treatment must be stopped. Diagnostic sets include polypeptide with sequence, given in materials, where Thr90 of polypeptide is phosphorylated.
EFFECT: described are methods for detection of presence or metastases of tumour, screening for presence of tumour among high risk population, prognosis for patient with tumour, determination of efficiency of surgery, radiotherapy or chemical therapy.
27 cl, 20 dwg, 18 ex
Title | Year | Author | Number |
---|---|---|---|
NEW TUMOUR BIOMARKER | 2010 |
|
RU2714750C2 |
DIAGNOSTIC ASSAYS AND KITS FOR DETECTION OF FOLATE RECEPTOR 1 | 2013 |
|
RU2668824C2 |
METHOD FOR DETECTING MALIGNANT TUMOURS | 2014 |
|
RU2671497C2 |
METHOD FOR DETECTION OF MALIGNANT TUMOURS | 2009 |
|
RU2519089C2 |
METHOD FOR CANCER DETECTION | 2013 |
|
RU2646466C2 |
METHOD FOR CANCER DETECTION | 2013 |
|
RU2646464C2 |
DIAGNOSTIC ANALYSES AND KITS FOR DETECTION OF FOLATE RECEPTOR 1 | 2018 |
|
RU2788126C2 |
HUMAN TUMOUR-ASSOCIATED MONOCLONAL ANTIBODY | 2008 |
|
RU2488593C2 |
SOLUBLE CD3 STABLE PHARMACEUTICAL COMPOSITIONS | 2006 |
|
RU2426743C2 |
MEDICATION FOR IMMUNITY INDUCTION AND METHOD OF MALIGNANT TUMOUR IDENTIFICATION | 2009 |
|
RU2519675C2 |
Authors
Dates
2015-10-27—Published
2010-08-11—Filed